W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies

News

22 October, 2025
Recommendation of the President – Tevimbra (tislelizumab)
read more
22 October, 2025
Recommendation of the President – Imfinzi (durvalumab)
read more
17 October, 2025
Publication AWA
read more
14 October, 2025
Recommendation of the President – the determination of mitotane concentration in blood serum
read more
13 October, 2025
Start of the second edition of Collegium AOTMiT – October 14
read more
10 October, 2025
The Transparency Council meeting 45/2025 on 20 October 2025
read more
10 October, 2025
The Transparency Council meeting 45/2025 on 20 October 2025
read more
10 October, 2025
Publication AWA
read more
10 October, 2025
Status of work in October
read more
10 October, 2025
Opinion of the President – Health policy program for pneumococcal vaccination for people over 55 years of age living in the municipality of Ustroń for the years 2026-2030
read more
10 October, 2025
Opinion of the President – Municipal program for the promotion of mental health among the residents of the Boguchwała Municipality for the years 2025-2026
read more
10 October, 2025
Opinion of the President – Health Prevention Program for the Early Detection of Vision Impairments in Children in the City of Poznań
read more
10 October, 2025
Opinion of the President – Prevention of hearing loss among secondary school students in the Zawiercie County for the years 2026-2028
read more
08 October, 2025
Recommendation of the President – qualification of adult patients for palliative and hospice care
read more
08 October, 2025
Recommendation of the President regarding #PPZ #48aa – Prevention of dental caries in children and adolescents
read more
07 October, 2025
Recommendation of the President – Givlaari (givosiran)
read more
07 October, 2025
The Transparency Council meeting 44/2025 on 13 October 2025
read more
03 October, 2025
Publication AWA
read more
02 October, 2025
Recommendation of the President #HPP #48aa – Prevention of tick-borne diseases (Lyme disease)
read more
29 September, 2025
Recommendation of the President – Praluent (alirocumab)
read more
29 September, 2025
Recommendation of the President – Repatha (evolocumab)
read more
29 September, 2025
Recommendation of the President – Leqvio (inlisiran)
read more
26 September, 2025
Publication AWA
read more
26 September, 2025
Status of work in September
read more

Home page

News Publications Publikacje BIP

#webinar agenda Aktualności announcement of the President azathioprinum Bimzelx Collegium AOTMiT colorectal cancer communication Communication from the Transparency Council Communication on the Tariff Council Cost Accounting Standard Council for Tariffs Affairs covering neonatal care cyclophosphamidum Data acquisition dental treatment services diseases of the organ of vision drug programme Empliciti entecavirum etanercept Fycompa gastroscopy glaucoma health policy program health policy programme health policy programme on breast cancer health policy programme on infertility treatment Health Policy Programmes Impavido in vitro Inovelon Jardiance Meeting of the Transparency Council methotrexatum Milupa Basic-P minimum wage increases mycophenolate mofetil new new tariffs news Notice Notice of the President Ontozry Onureg Opdivo Opdivo (nivolumab)opinion Opinion of the President Opinion of the Transparency Council Ospolot Ozurdex perinatal care Ponvory Position of the Transparency Council Press conference Recommendation Recommendation of the President Renastep report Rezurock sirolimus Suliqua Tariff Council Tariffs Council Tarification Plan 2025 tenofovirum disoproxilum the drug programme B.44 the drug programme B.82 The Meeting of the Tariffs Council trainings Transparency Council Tremfya update Vivitrol Yervoy

Pokaż więcej ↓

Pokaż mniej ↑

Telefon

Page header

News

Recommendation of the President – Tevimbra (tislelizumab)

Recommendation of the President – Imfinzi (durvalumab)

Publication AWA

Recommendation of the President – the determination of mitotane concentration in blood serum

Start of the second edition of Collegium AOTMiT – October 14

The Transparency Council meeting 45/2025 on 20 October 2025

The Transparency Council meeting 45/2025 on 20 October 2025

Publication AWA

Status of work in October

Opinion of the President – Health policy program for pneumococcal vaccination for people over 55 years of age living in the municipality of Ustroń for the years 2026-2030

Opinion of the President – Municipal program for the promotion of mental health among the residents of the Boguchwała Municipality for the years 2025-2026

Opinion of the President – Health Prevention Program for the Early Detection of Vision Impairments in Children in the City of Poznań

Opinion of the President – Prevention of hearing loss among secondary school students in the Zawiercie County for the years 2026-2028

Recommendation of the President – qualification of adult patients for palliative and hospice care

Recommendation of the President regarding #PPZ #48aa – Prevention of dental caries in children and adolescents

Recommendation of the President – Givlaari (givosiran)

The Transparency Council meeting 44/2025 on 13 October 2025

Publication AWA

Recommendation of the President #HPP #48aa – Prevention of tick-borne diseases (Lyme disease)

Recommendation of the President – Praluent (alirocumab)

Recommendation of the President – Repatha (evolocumab)

Recommendation of the President – Leqvio (inlisiran)

Publication AWA

Status of work in September